Skip To Main Content
Kevin Bardosh on Muck Rack

Kevin Bardosh

As seen in: Daily Mail, The Telegraph, PLOS, Journal of Medical Ethics (JME), Globalization and Health, Baltimore Sun, The Epoch Times, Washington Examiner, The Lancet, The Wire (India) and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kevin

Contact Kevin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

La terapia que podría erradicar el SIDA para siempre

|
By Kevin Bardosh
Una nueva terapia innovadora se encuentra en proceso de desarrollo clínico acelerado y la aprobación regulatoria por parte de la FDA Un médico analiza una muestra de suero bajo un microscopio en un laboratorio de microbiología de la Facultad de Medicina de la Universidad de Washington en Seattle, Washington, el 11 de diciembre de 2020. (Karen Ducey/Getty Images) 4 de febrero de 2026, 10:37 p. m. | Actualizado el4 de febrero de 2026, 10:37 p. m.
Open in Who Shared Issue with article?

Ending AIDS Deaths: A Test of American Resolve for the FDA

|
By Kevin Bardosh
| The Epoch Times
Ending AIDS Deaths: A Test of American Resolve for the FDA A new breakthrough therapy is up for accelerated clinical development and regulatory approval at the FDA. The United States stands at the threshold of a rare public health inflection point: ending AIDS-related deaths within our lifetime. We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.
Open in Who Shared Issue with article?

America has an Alzheimer’s problem. Can Trump fix it?

|
By Kevin Bardosh
| Washington Examiner Verified
America has an Alzheimer’s problem, devastating families and driving soaring healthcare costs. More than 7 million people over 65 years old live with Alzheimer’s dementia today, a number predicted to double by 2050. Costs are staggering, by some estimates over $1 trillion per year, which may climb to $3 trillion by 2050, or 10% of our current GDP.
Open in Who Shared Issue with article?
See all 33 licensed articles (40 Total)